AYTU BIOPHARMA, INC Accounts Payable
AYTU BIOPHARMA, INC (AYTU) had Accounts Payable of $11.28 million as of 2026-06-30, per its 10-K filed 2026-09-22.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2026-09-22
- 2026-06-30: Accounts Payable, Current $11.28M.
- 2026-03-31: Accounts Payable, Current $13.21M.
- 2025-12-31: Accounts Payable, Current $14.26M.
- 2025-09-30: Accounts Payable, Current $12.34M.
| Period end | Accounts Payable, Current | Accounts Payable, Current as first filed |
|---|---|---|
| 2026-06-30 | $11.28M 10-K · filed 2026-09-22 | |
| 2026-03-31 | $13.21M 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $14.26M 10-Q · filed 2026-02-03 | |
| 2025-09-30 | $12.34M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $10.60M 10-K · filed 2026-09-22 | |
| 2025-03-31 | $12.04M 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $11.70M 10-Q · filed 2025-02-12 | |
| 2024-09-30 | $13.51M 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $10.31M 10-K · filed 2025-09-23 | $10.44M 10-K · filed 2024-09-26 |
| 2024-03-31 | $10.47M 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $10.47M 10-Q · filed 2024-02-14 | |
| 2023-06-30 | $13.48M 10-K · filed 2024-09-26 | |
| 2021-06-30 | $19.25M 10-K · filed 2021-09-28 | |
| 2021-03-31 | $16.53M 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $7.16M 10-Q · filed 2021-02-11 | |
| 2020-09-30 | $5.77M 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $11.64M 10-K · filed 2021-09-28 | $11.82M 10-K · filed 2020-10-06 |
| 2020-03-31 | $6.96M 10-Q · filed 2020-05-15 | |
| 2019-12-31 | $9.60M 10-Q · filed 2020-02-14 | |
| 2019-09-30 | $2.63M 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $2.13M 10-K · filed 2020-10-06 | $2.30M 10-K · filed 2019-09-26 |
| 2019-03-31 | $2.13M 10-Q · filed 2019-05-14 | |
| 2018-12-31 | $2.37M 10-Q · filed 2019-05-14 | |
| 2018-09-30 | $2.11M 10-Q · filed 2018-11-07 | |
| 2018-06-30 | $2.12M 10-K · filed 2019-09-26 | |
| 2018-03-31 | $3.20M 10-Q · filed 2018-05-14 | |
| 2017-12-31 | $3.41M 10-Q · filed 2018-02-08 | |
| 2017-09-30 | $1.66M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $2.22M 10-K · filed 2018-09-06 | |
| 2017-03-31 | $1.41M 10-Q · filed 2017-05-11 | |
| 2016-06-30 | $2.32M 10-K · filed 2017-08-31 | |
| 2015-03-31 | $546.35K 10-Q · filed 2015-05-19 | |
| 2015-02-28 | $4.27K 10-Q · filed 2015-04-15 | |
| 2014-11-30 | $3.58K 10-Q · filed 2015-01-12 | |
| 2014-08-31 | $310.00 10-Q · filed 2015-04-15 | |
| 2014-06-30 | $649.50K 10-Q · filed 2015-05-19 | |
| 2014-05-31 | $3.01K 10-Q · filed 2014-07-10 | |
| 2014-02-28 | $11.11K 10-Q · filed 2014-04-11 | |
| 2013-11-30 | $12.76K 10-Q · filed 2014-01-10 | |
| 2013-08-31 | $6.84K 10-K · filed 2014-11-26 | |
| 2013-05-31 | $7.40K 10-Q · filed 2013-06-28 | |
| 2013-02-28 | $14.02K 10-Q · filed 2013-04-15 | |
| 2012-11-30 | $12.05K 10-Q · filed 2013-01-14 | |
| 2012-08-31 | $5.84K 10-K · filed 2014-11-26 | |
| 2012-05-31 | $4.13K 10-Q · filed 2012-06-26 | |
| 2012-02-29 | $3.90K 10-Q · filed 2012-04-12 | |
| 2011-11-30 | $5.46K 10-Q · filed 2011-12-23 | |
| 2011-08-31 | $330.00 10-K · filed 2012-11-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |